High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients with High-risk Stage 3 Neuroblastoma: 10-Year Experience at a Single Center

High-dose chemotherapy and autologous stem cell rescue (HDCT/ASCR) was applied to improve the prognosis of patients with high-risk stage 3 neuroblastoma. From January 1997 to December 2006, 28 patients were newly diagnosed as stage 3 neuroblastoma. Nine of 11 patients with N-myc amplification and 5...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Suh, Jung Min, Yoo, Keon Hee, Sung, Ki Woong, Kim, Ju Youn, Cho, Eun Joo, Koo, Hong Hoe, Lee, Suk Koo, Kim, Jhingook, Lim, Do Hoon, Suh, Yeon Lim, Kim, Dae Won
Format: Artigo
Langue:Inglês
Publié: The Korean Academy of Medical Sciences 2009
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2719186/
https://ncbi.nlm.nih.gov/pubmed/19654949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.4.660
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires